BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11765101)

  • 1. Protocol Underemphasizes beta-blockers.
    Chase SL
    J Am Pharm Assoc (Wash); 2001; 41(6):793-4. PubMed ID: 11765101
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment for heart failure: good news and bad.
    Assomull R; Elliott PM
    Hosp Med; 2005 Feb; 66(2):102-5. PubMed ID: 15739707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(3):171-2. PubMed ID: 17319102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic cardiac failure in 1997: obvious facts and uncertainties].
    Komajda M
    Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1205-7. PubMed ID: 9488765
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Betablockers and the treatment of chronic heart failure].
    Martínez Martínez JA
    Medicina (B Aires); 1999; 59(6):793-7. PubMed ID: 10752230
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular basis for therapeutic choices in heart failure.
    Opie LH
    Circulation; 2004 Oct; 110(17):2559-61. PubMed ID: 15505109
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of heart failure in the elderly patient with comorbidities.
    Briscoe TA; Earle SR; Lob MK; Somerville LL
    Director; 2004; 12(1):36-41. PubMed ID: 19178116
    [No Abstract]   [Full Text] [Related]  

  • 9. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure.
    McKelvie R
    Clin Evid; 2004 Dec; (12):115-43. PubMed ID: 15865633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-blockers in the treatment of systolic dysfunction after myocardial infarction. Closing the circle?].
    Martínez Martínez JA
    Medicina (B Aires); 2001; 61(3):376-7. PubMed ID: 11474890
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
    Jessup M; Banner N; Brozena S; Campana C; Costard-Jäckle A; Dengler T; Hunt S; Metra M; Rahmel A; Renlund D; Ross H; Warner Stevenson L
    J Heart Lung Transplant; 2006 Sep; 25(9):1003-23. PubMed ID: 16962463
    [No Abstract]   [Full Text] [Related]  

  • 13. Conclusions on the management of heart failure.
    Swedberg K
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
    van der Horst IC; Voors AA; van Veldhuisen DJ
    Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin in patients with heart failure.
    Böhm M
    N Engl J Med; 1997 Jul; 337(2):129-30; author reply 130-1. PubMed ID: 9221339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Particular aspects of heart failure in elderly patients].
    Peperstraete B
    Rev Med Brux; 2006; 27(5):430-6. PubMed ID: 17144642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?
    Hoppe UC
    Clin Res Cardiol; 2007 Apr; 96(4):196-8. PubMed ID: 17294351
    [No Abstract]   [Full Text] [Related]  

  • 18. 15 years of heart-failure trials: what have we learned?
    Massie BM
    Lancet; 1998 Aug; 352 Suppl 1():SI29-33. PubMed ID: 9736477
    [No Abstract]   [Full Text] [Related]  

  • 19. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.